PERSONALISED MEDICINE OFFERS HUGE OPPORTUNITIES, BUT MAJOR CHALLENGES FOR PHARMA SECTOR
June 1st, 2011
BY KEITH NUTHALL
PERSONALISED medicines are one of those innovations that are so patently a good idea, it is almost inconceivable that they will not be the norm in 10 or 20 years' time. Taking pharmaceuticals without checking your molecular make up for side-effect risks will probably be seen as dumb, or worse, the subject of negligence claims. It will be like force feeding a baby peanuts before their allergy risk is known.
Because, as Thomas Metcalfe, chair of the personalised medicines task force of the European Biopharmaceutical Enterprises, told a recent ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.